You are here

  • Home
  • Archive
  • Volume 6, Issue 3
  • Review: lipid lowering drugs decrease coronary artery disease (CAD) events but not all cause or CAD mortality in men with no history of CAD

Article Text

Article menu
Download PDFPDF
Therapeutics
Review: lipid lowering drugs decrease coronary artery disease (CAD) events but not all cause or CAD mortality in men with no history of CAD

https://doi.org/10.1136/ebm.6.3.85

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    (2000) BMJ 321, 983. Pignone M, Phillips C, Mulrow C. . Use of lipid lowering drugs for primary prevention of coronary heart disease: meta analysis of randomised trials.. Oct 21;. :. –6.
    OpenUrlAbstract/FREE Full Text

    
 
 QUESTION: In patients with no history of coronary artery disease (CAD), does a lipid lowering drug (cholestyramine, gemfibrozil, pravastatin, or lovastatin) decrease the risk for CAD events, CAD mortality, or all cause mortality?

    Data sources

    English language studies were identified by searching Medline (1994 to June 1999) with the Medical Subject Headings (MeSH) hyperlidemia and anti cholesterolemic agents and with MeSH or keywords identifying randomised controlled trials and individual drug names, the Cochrane Clinical Trials Registry, and bibliographies of systematic reviews and clinical practice guidelines.

    Study selection

    Randomised controlled trials were selected if they had ≥1 year of duration and measured CAD events, CAD mortality, and all cause mortality. Exclusion criteria were studies of secondary prevention or studies published in abstract form …

    View Full Text

    Footnotes

    • Source of funding: Agency for Healthcare Research and Quality.

    • For correspondence: Dr M Pignone, Division of General Internal Medicine, 5039 Old Clinic Building, University of North Carolina, Chapel Hill, NC 27599-7110, USA. Fax + 1 919 966 2274.